J Pediatr Hematol Oncol
November 2021
Background: Coronavirus disease-2019 (COVID-19) could be associated with morbidity and mortality in immunocompromised children.
Objective: The objective of this study was to measure the frequency of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among hospitalized children with cancer and to detect the associated clinical manifestations and outcomes.
Methodology: A prospective noninterventional study including all hospitalized children with cancer conducted between mid-April and mid-June 2020 in Ain Shams University Hospital, Egypt.